PDS Biotechnology PDSB
NASDAQ PDSB
$1.16 -0.08 (-6.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Return on Sales [ROS] (2021 - 2022)

Updated

Analysis

PDS Biotechnology (PDSB) Return on Sales [ROS] (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 24.35%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 37.86%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -3.52%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 32.97%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 20.57%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -133.21%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 28.37%
10 PDS Biotechnology 60.39 Mn -30.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -9,514.34%
Mar 31, 2022 -148,758.28%
Dec 31, 2021 -365,627.01%
Sep 30, 2021 -512,689.54%
API Access

PDS Biotechnology Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEY